Advertisement

Topics

Omni Bio Pharmaceutical, Inc. Company Profile

15:29 EDT 18th March 2019 | BioPortfolio

Omni Bio Pharmaceutical, Inc. (www.omnibiopharma.com) is an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential. Omni Bio's core technology and pipeline are based on issued and pending patents licensed from the University of Colorado Denver ("UCD") and a privately held corporation surrounding the broader therapeutic potential of currently marketed therapies. One of Omni Bio's lead development programs is evaluating an FDA-approved, off-patent drug, AAT, for the treatment of Type 1 diabetes. Novel discoveries made at UCD indicate that AAT has the potential to address a variety of indications in the areas of bacterial and viral disorders, biohazards, diabetes and transplant rejection.


News Articles [290 Associated News Articles listed on BioPortfolio]

Hologic secures CE mark for three-in-one Omni hysteroscope

Hologic said the Omni Hysteroscope has been designed to help Obstetricians and gynecologists (ObGyns) for both in- and out-patient settings and help ObGyns simplify the process of diagnosing The post...

Corin to buy US surgical robotics firm OMNI Orthopaedics

Established in 1999, OMNI is at the forefront of robotic-assisted knee replacement. The OMNIBotics is claimed to be a total knee replacement solution which combines a robotic cutting The post Corin t...

Omnicom Agencies Celebrate 2018 with a Stellar Performance at Campaign Asia Agency of the Year ...

NEW YORK and SINGAPORE, Dec. 14, 2018 /PRNewswire/ -- Omnicom agencies continued their tradition of delivering outstanding creativity and effectiveness by winning 75 Agency of Read more...

Larvol Launches Omni, Its Next Gen KOL and Pharma Tracking Tool

Larvol, a San Francisco-based pharma SaaS (Software as a Service) company, announced the launch of Omni, their newest Medical Communications and Competitive Intelligence tool at t...

Omni Premier Marketing Welcomes Paul Jerez as Their New Director of Dental Business Development

Omni Premier Marketing is excited to announce Paul Jerez as their Director of Dental Business Development. Omni Premier is also proud to celebrate the promotion of Kaitlynne Tatum to Director of Marke...

Hologic's next-gen hysteroscope debuts in US

Hologic has announced the US launch of its next-generation Omni hysteroscope after it received 510(k) clearance from the FDA  -More- 

Motive Partners Announces Acquisition of Finantix

NEW YORK and LONDON, December 11, 2018 /PRNewswire/ -- Finantix is a leading provider of technology enabling the digitalization of omni-channel advisory, sales and services Read more...

JTV® Launches New Bella Luce Luxe™ Collection set with Zirconia from Swarovski®

KNOXVILLE, Tenn., Nov. 6, 2018 /PRNewswire/ -- JTV (Jewelry Television®), the leading omni-digital retailer of jewelry and gemstones in the U.S., today announced its newest Read more...

PubMed Articles [447 Associated PubMed Articles listed on BioPortfolio]

Validation of the OMNI vocal effort scale in the treatment of adductor spasmodic dysphonia.

To establish the validity of the OMNI Vocal Effort Scale (OMNI-VES) for resistance exercise, a single-question pictorial scale, in voice-related perceived exertion. Additionally, the study aimed to as...

IPADAM "Pharmaceutical interventions on the issue of pharmaceutical records and self-medication" quanti survey in 482 French pharmacies.

This study aims to: (i) quantify the number of pharmaceutical interventions (PIs) linked to spontaneous requests for the two oral target molecules, ibuprofen and pseudoephedrine (ii) analyse the cause...

A practical omni-directional SH wave transducer for structural health monitoring based on two thickness-poled piezoelectric half-rings.

Structural health monitoring (SHM) has become more and more important in modern industries as it can monitor the safety of structures during the full service life and prevent possible losses of life a...

H NMR analytical characterization of mineral oil hydrocarbons (PARAFFINS) for pharmaceutical use.

3D Printing of Pharmaceutical and Medical Applications: a New Era.

Clinical Trials [365 Associated Clinical Trials listed on BioPortfolio]

Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.

The study enrolles all consecutive patients undergoing cardiac surgery at the European Hospital, Rome. The population undergoes randomization to receive usual surgical hemostasis or added ...

Nutritious Eating With Soul (The NEW Soul Study)

This study addresses two challenges seen among African American (AA)participants during previous weight loss and dietary interventions aimed at reducing cardiovascular disease (CVD) risk: ...

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma

This study will prospectively assess the clinical effect of ab‐interno transluminal viscoelastic delivery and trabeculotomy performed using the OMNI Surgical System in combination with C...

Companies [1088 Associated Companies listed on BioPortfolio]

Omni Bio Pharmaceutical, Inc.

Omni Bio Pharmaceutical, Inc. (www.omnibiopharma.com) is an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercializa...

OMNI Systems, Inc.

OMNI Systems™, Inc. was founded in 1990, with headquarters in Cleveland, Ohio. OMNI Systems has quickly become one of the largest, privately-owned label convertors in the Uni...

Omni Hotels & Resorts

Omni Hotels & Resorts creates genuine, authentic guest experiences at 45 distinct luxury hotels and resorts in leading business gateways and leisure destinations across North America. From exceptiona...

Virtuix

Founded by CEO Jan Goetgeluk in April 2013 and headquartered in Houston, Texas, Virtuix is at the forefront of virtual reality hardware and is the developer of the Omni – the...

TogoRun

Omnicom Group Inc. (NYSE: OMC) (www.omnicomgroup.com) is a leading global advertising, marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide a...

More Information about "Omni Bio Pharmaceutical, Inc." on BioPortfolio

We have published hundreds of Omni Bio Pharmaceutical, Inc. news stories on BioPortfolio along with dozens of Omni Bio Pharmaceutical, Inc. Clinical Trials and PubMed Articles about Omni Bio Pharmaceutical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Omni Bio Pharmaceutical, Inc. Companies in our database. You can also find out about relevant Omni Bio Pharmaceutical, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record